Literature DB >> 29807507

Septic Arthritis/Osteomyelitis May Lead to Osteochondrosis-Like Lesions in Foals.

Bjørn Wormstrand1, Liv Østevik1, Stina Ekman2, Kristin Olstad1.   

Abstract

Failure of the cartilage canal blood supply leads to ischemic chondronecrosis which causes osteochondrosis, and osteochondral lesions. Osteochondrosis is a disease with a heritable component and usually occurs under aseptic conditions. Because bacteria can bind to growth cartilage and disrupt the blood supply in pigs and chickens, we considered whether this might play a role in development of equine osteochondrosis. The aim of this study was to examine whether bacteria are present in canals in the growth cartilage of foals with septic arthritis/osteomyelitis, and whether this is associated with osteochondrosis. The material consisted of 7 foals aged 9-117 days euthanized because of septic arthritis/osteomyelitis. The 7 cases had 16 lesions in growth cartilage that were evaluated histologically. Bacteria were present in cartilage canals in foals with septic arthritis/osteomyelitis. Portions of necrotic canals adjacent to bacteria frequently contained neutrophils, termed acute septic canals; or granulation tissue with neutrophils, termed chronic septic canals. Acute and chronic septic canals were associated with ischemic chondronecrosis in the articular-epiphyseal cartilage complex (AECC) of 5 cases and in the physis of 2 cases, and ossification was focally delayed in 5 of those 7 cases. Lesions occurred with and without adjacent osteomyelitis. Bacteria were present in cartilage canals and were associated with focal chondronecrosis in both the AECC and the physis. This establishes sepsis as a plausible cause of some osteochondral lesions in horses. It is recommended that horses with sepsis-related osteochondral lesions may be used for breeding without increasing the prevalence of OCD-predisposing genes in the population.

Entities:  

Keywords:  bacteria; cartilage canals; foal; growth cartilage; histology; osteochondral lesions; septic arthritis

Mesh:

Year:  2018        PMID: 29807507     DOI: 10.1177/0300985818777786

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  7 in total

Review 1.  Imaging of osteochondrosis.

Authors:  Elizabeth Yuan West; Diego Jaramillo
Journal:  Pediatr Radiol       Date:  2019-11-04

2.  Cervical articular process joint osteochondrosis in Warmblood foals.

Authors:  Wilhelmina Bergmann; Marjolijn de Mik-van Mourik; Stefanie Veraa; Jan van den Broek; Inge D Wijnberg; Willem Back; Andrea Gröne
Journal:  Equine Vet J       Date:  2020-02-21       Impact factor: 2.888

3.  Prevalence of osteochondral lesions in the fetlock and hock joints of Standardbred horses that survived bacterial infection before 6 months of age.

Authors:  Eli H S Hendrickson; Sigrid Lykkjen; Nils I Dolvik; Kristin Olstad
Journal:  BMC Vet Res       Date:  2018-12-10       Impact factor: 2.741

4.  Computed tomographic development of physeal osteochondrosis in pigs.

Authors:  Kristin Olstad; Bjørn Wormstrand; Jørgen Kongsro; Eli Grindflek
Journal:  BMC Vet Res       Date:  2019-12-17       Impact factor: 2.741

5.  A method for labelling lesions for machine learning and some new observations on osteochondrosis in computed tomographic scans of four pig joints.

Authors:  Kristin Olstad; Lars Erik Gangsei; Jørgen Kongsro
Journal:  BMC Vet Res       Date:  2022-08-31       Impact factor: 2.792

Review 6.  Cartilage-gut-microbiome axis: a new paradigm for novel therapeutic opportunities in osteoarthritis.

Authors:  Jean-Marie Berthelot; Jérémie Sellam; Yves Maugars; Francis Berenbaum
Journal:  RMD Open       Date:  2019-09-20

7.  Osteochondrosis and other lesions in all intervertebral, articular process and rib joints from occiput to sacrum in pigs with poor back conformation, and relationship to juvenile kyphosis.

Authors:  Kristin Olstad; Torunn Aasmundstad; Jørgen Kongsro; Eli Grindflek
Journal:  BMC Vet Res       Date:  2022-01-18       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.